Copenhagen, Hovedstaden, Denmark Dansk Erhvervsinvestering is the famous VC, which was founded in 1983.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Genmab, PremiTech. Among the most successful fund investment fields, there are Biotechnology, SaaS.
This Dansk Erhvervsinvestering works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2000. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Dansk Erhvervsinvestering, startups are often financed by BankInvest Biomedical Venture. The meaningful sponsors for the fund in investment in the same round are BankInvest Biomedical Venture, Northcap, LODH Immunology Fund. In the next rounds fund is usually obtained by LODH Immunology Fund, Index Ventures, GlaxoSmithKline.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aol Ventures | New York, New York, United States |
| Cambium Grove Capital | - |
| Cole Taylor Bank | Chicago, Illinois, United States |
| Firlej Kastory | Mazowieckie, Poland, Warsaw |
| FRB Capital Group | - |
| Jincheng Boshi | Beijing, Beijing, China |
| Kansas City Equity Partners | Kansas City, Missouri, United States |
| Orbit Venture Partners | - |
| Plymouth Growth Partners | Ann Arbor, Michigan, United States |
| Qingquanshi Capital | Beijing, Beijing, China |
| Ridgeline Ventures | Boulder, Colorado, United States |
| Rukam Capital Trust | Kyonggi-do, Seongnam, South Korea |
| Salesforce | California, San Francisco, United States |
| Schibsted | Norway, Oslo |
| Shenzhen Lanshi Venture Capital | China, Guangdong, Shenzhen |
| Softbank China & India Holdings | China, Hong Kong, Hong Kong Island |
| Start'Act | Gabès, Tunis, Tunisia |
| UpWest Labs | California, Palo Alto, United States |
| Yingsheng Futong | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 